# University of Strathclyde

> University of Strathclyde is a VC fund backing Biotechnology and Medical. See 37 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Glasgow, United Kingdom
- Total investments: 37
- Last investment: Aug 2026
- Lead investor: 3%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/school/university-of-strathclyde
- X (Twitter): http://twitter.com/unistrathclyde
- Website: http://www.strath.ac.uk/
- Facebook: http://www.facebook.com/universityofstrathclyde

University of Strathclyde is a VC fund in Glasgow focused on Biotechnology and Medical. The University of Strathclyde provides higher education programs across undergraduate, postgraduate, and research levels, with a focus on teaching, applied research, and knowledge exchange. The institution offers postgraduate taught and research degrees, supported by a range of scholarship options designed to assist students with academicprogression. Research activity spans multiple disciplines and informs curriculum development, industry collaboration, and public impact initiatives.

## Contacts

5 contacts available for University of Strathclyde. Shizune tracks 10 team members at University of Strathclyde. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/university-of-strathclyde?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 7 | 19% |
| Medical | 4 | 11% |
| Health Care | 4 | 11% |
| Health Diagnostics | 4 | 11% |
| Renewable Energy | 3 | 8% |

39 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 17 | 46% |
| Pre-Seed | 5 | 14% |
| Series A | 3 | 8% |
| Funding Round | 2 | 5% |
| Venture - Series Unknown | 2 | 5% |

6 stages tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Craig Clark | Professor of Practice, Space | 0 | https://shizune.co/investors/profile/craig-clark-89c1 |
| Lilian Edwards | Professor of Internet Law | 0 | https://shizune.co/investors/profile/lilian-edwards |
| Pawel Niewczas | Professor | 0 | https://shizune.co/investors/profile/pawel-niewczas |
| Cameron Graham | Entrepreneurial Ambassador | 0 | https://shizune.co/investors/profile/cameron-graham |
| Campbell Booth | Vice Dean - Research | 0 | https://shizune.co/investors/profile/campbell-booth |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Mironid | Google Analytics is a web analysis service provided by Google. Google utilizes the data collected to track and examine the use of www.mironid.com, to prepare reports on its activities and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network. | $46M | Series B | Aug 05, 2026 |  |
| QuickBlock | QuickBlock is a flat-packed, recycled plastic, modular building system that offers an alternative to traditional concrete blocks. | $1.3M | Venture - Series Unknown | Jul 23, 2026 |  |
| Northern Light Microscopy | Northern Light Microscopy's mission is to use cutting-edge imaging technology to enable life-science labs and businesses to unlock bioscience discoveries. | $1.4M | Pre-Seed | Apr 22, 2026 |  |
| Regeno Energy | Regeno Resources accelerating the goal of clean energy with inexpensive, self-installing wind turbines. | $564.4K | Pre-Seed | Mar 20, 2026 |  |
| Biomarx | Biomarx specializes in automated genomic diagnostics. The company develops rapid, low-cost liquid biopsy solutions to enable early lung cancer detection and replace traditional genome sequencing in clinical settings. | $940.5K | Pre-Seed | Jan 05, 2026 |  |
| Sentinel | Sentinel is a wellness firm offering trauma prevention and management through their application and scientific expertise. | $1.6M | Seed | Nov 25, 2025 |  |
| Seluna | Seluna believes that innovation and diagnosis are the cornerstones of modern medicine. Seluna is passionate about tackling complex, real-world medical problems in order to make a significant difference. | $878K | Seed | Aug 28, 2025 |  |
| ScreenIn3D | ScreenIn3D utilizes the latest advances in microfluidics and 3D culture to develop a unique microfluidic screening platform for precision medicine. | $1M | Seed | Jun 12, 2025 |  |
| ZOEX | ZOEX is the world's first wave energy converter system that is dependable, modular, and commercially feasible. | $452.7K | Seed | May 27, 2025 |  |
| Dxcover | Dxcover is a clinical-stage liquid biopsy firm that is developing diagnostics for the early diagnosis of numerous malignancies, when treatment has a better possibility of having an influence on outcomes. The business was the first to use infrared spectroscopy of circulating pan-omic indicators to detect and identify cancer. The business hasgenerated compelling clinical data on the diagnosis of Stage I and Stage II malignancies with high accuracy.Dxcover was established in 2016 in Glasgow, Glasgow City by David S Palmer, Holly Butler, and Matthew Baker. | $6.2M |  | Feb 03, 2025 |  |

10 of 37 investments shown.

## Co-investors
- [Scottish Enterprise](https://shizune.co/investors/profile/scottish-enterprise) — VC Fund, 21 deals together
- [SIS Ventures](https://shizune.co/investors/profile/sis-ventures) — VC Fund, 9 deals together
- [Equity Gap](https://shizune.co/investors/profile/equity-gap) — VC Fund, 8 deals together
- [Scottish Investment Bank](https://shizune.co/investors/profile/scottish-investment-bank) — VC Fund, 8 deals together
- [Eos](https://shizune.co/investors/profile/eos-advisory) — VC Fund, 7 deals together
- [Gabriel Investments](https://shizune.co/investors/profile/gabriel-investments-2) — VC Fund, 7 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does University of Strathclyde invest in?

University of Strathclyde invests primarily in Biotechnology, Medical and Health Care startups, most often at Seed and Pre-Seed stage. Most of the 37 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact University of Strathclyde?

Public channels for University of Strathclyde include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at University of Strathclyde?

The team at University of Strathclyde includes Craig Clark (Professor of Practice, Space), Lilian Edwards (Professor of Internet Law) and Pawel Niewczas (Professor), among 10 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co